Oncology

  1. 04 Jul 2016  |  North America

    The Global Immuno-oncology Therapeutics Market—Checkpoint Inhibitors

    The Next Generation of Cancer Therapies

    Immuno-oncology is based on the premise that tumors escape detection by the immune system, contributing to their growth and progression. Checkpoint inhibitor pathways act as the checks and balances that allow T-cells to recognize foreign substances or tumors. This global study looks at the immune-oncology therapeutics pipeline for checkpoint inhibi...

    $8,000.00

    Special Price $6,000.00 save 25 %

  2. 24 Feb 2015  |  Asia Pacific

    Analysis of the Global Oncology Drug Delivery Market

    Future Impact of Emerging Technologies

    The global oncology drug delivery market (or oncolytics market) was worth $91.00 billion in 2013 and has been growing at an annual rate of 5.0%. The market, which includes drug delivery systems for cancer therapy and cancer pain, is expected to generate $100.96 billion in 2015. The oral drug delivery systems segment accounted for an estimated 25.0%...

    $4,950.00

    Special Price $3,712.50 save 25 %